Assertio Holdings, Inc.

SecurityASRT / Assertio Holdings, Inc.
InstitutionSquarepoint Ops LLC
Latest Disclosed Ownership17,892 shares
Latest Disclosed Value $ 341,022
Squarepoint Ops LLC ownership in ASRT / Assertio Holdings, Inc.

On May 15, 2026 - Squarepoint Ops LLC filed a 13F-HR form disclosing ownership of 17,892 shares of Assertio Holdings, Inc. (US:ASRT) valued at $341,022 USD as of March 31, 2026. The entity filed a previous 13F-HR on November 14, 2025 disclosing 0 shares of Assertio Holdings, Inc.. The current value of the position is $419,925 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ASSERTIO HOLDINGS COM NEW 04546C304 17,892 17,892 341 0.0004
2020-05-15 2020-03-31 13F ASSERTIO THERAPEUTICS COM 04545L107 0 -451,147 -100.00 0 -100.00
2020-02-14 2019-12-31 13F ASSERTIO THERAPEUTICS COM 04545L107 451,147 397,417 739.66 564 717.39 0.0034
2019-11-14 2019-09-30 13F ASSERTIO THERAPEUTICS COM 04545L107 53,730 -50,337 -48.37 69 -80.78 0.0006
2019-08-14 2019-06-30 13F ASSERTIO THERAPEUTICS COM 04545L107 104,067 16,658 19.06 359 -18.96 0.0035
2019-05-15 2019-03-31 13F ASSERTIO THERAPEUTICS COM 04545L107 87,409 -271,728 -75.66 443 -65.82 0.0047
2019-02-14 2018-12-31 13F ASSERTIO THERAPEUTICS COM 04545L107 359,137 233,007 184.74 1,296 74.66 0.0151
2018-11-14 2018-09-30 13F ASSERTIO THERAPEUTICS COM 04545L107 126,130 -170,843 -57.53 742 -62.54 0.0089
2018-08-14 2018-06-30 13F DEPOMED COM 249908104 296,973 246,274 485.76 1,981 493.11 0.0263
2018-05-15 2018-03-31 13F DEPOMED COM 249908104 50,699 -168,201 -76.84 334 -81.04 0.0053
2018-02-14 2017-12-31 13F DEPOMED COM 249908104 218,900 16,015 7.89 1,762 49.96 0.0307
2017-11-14 2017-09-30 13F DEPOMED COM 249908104 202,885 38,195 23.19 1,175 -33.58 0.0226
2017-08-14 2017-06-30 13F DEPOMED COM 249908104 164,690 61,049 58.90 1,769 35.97 0.0348
2017-05-15 2017-03-31 13F DEPOMED COM 249908104 103,641 33,735 48.26 1,301 3.25 0.0359
2017-02-14 2016-12-31 13F DEPOMED COM 249908104 69,906 37,386 114.96 1,260 55.17 0.0515
2016-11-14 2016-09-30 13F DEPOMED COM 249908104 32,520 11,357 53.66 812 95.66 0.0539
2016-08-15 2016-06-30 13F DEPOMED COM 249908104 21,163 -100,304 -82.58 415 -75.47 0.0259
2016-05-16 2016-03-31 13F DEPOMED COM 249908104 121,467 30,082 32.92 1,692 2.11 0.1312
2016-02-16 2015-12-31 13F DEPOMED COM 249908104 91,385 91,385 1,657 0.1817
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.